Navigation Links
No Drop in I.Q. Seen After Bypass for Child Heart Surgery
Date:11/11/2008

Neurological Side Effects Not Found in School-Age Children with Less Complex Heart Defects

PHILADELPHIA, Nov. 11 /PRNewswire-USNewswire/ -- The use of cardiopulmonary bypass does not cause short-term neurological problems in children and teenagers after surgery for less complex heart defects, according to pediatric researchers. The new finding contrasts favorably with previous studies that showed adverse neurological effects after newborn surgery for more complex heart conditions.

"This is good news for school-aged children who receive surgery for these less complex heart defects," said study leader Michael D. Quartermain, M.D., a pediatric cardiologist at The Children's Hospital of Philadelphia. Quartermain presented the study group's results at the American Heart Association's Scientific Sessions yesterday in New Orleans.

The research, conducted at the Cardiac Center of Children's Hospital, studied 41 patients, aged five to 18, who underwent heart surgery at the hospital while a heart-lung machine circulated their blood (under cardiopulmonary bypass, or CPB). All the patients had milder forms of congenital heart disease usually characterized by an abnormal heart valve or by a hole between the heart's chambers.

Such defects, while present from birth, are often not detected until a patient is school age or even older. Patients do not show obvious symptoms and are otherwise healthy, but surgical intervention is often recommended to prevent complications later in life. In contrast, more complex congenital heart defects, such as hypoplastic left heart syndrome, a severely underdeveloped ventricle, are life-threatening in infancy, and require urgent surgical repair.

Previous studies of survivors of more complex heart surgery have found neurological problems, such as impaired motor development, lower I.Q. scores and reduced language skills. As medical regimens and surgical techniques have advanced, more recent studies have found
'/>"/>

SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. No drop in IQ seen after bypass for child heart surgery
2. Hispanics less likely to have repeat revascularizations 1 year after angioplasty
3. Banned Obesity Drug Tied to Heart Risks Long After Use
4. More People Living Longer After Cancer Diagnosis
5. How women can improve their quality of life after breast cancer treatment
6. Sudden Death Risk Highest 30 Days After Heart Attack
7. Cone-beam CT: Just as useful as MDCT before and after percutaneous vertebroplasty
8. Treating Osteoporosis After Hip Fracture
9. Beware of Ten Mistakes after Social Security Denies Disability Benefits
10. Promoting the healing process after a heart attack
11. New National Patient and Surgeon Surveys Show Post-Surgical Care Critical to Optimal Weight Loss After Bariatric Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2009)...SNewswire/ -- Acetaminophen is an ingredient found...es to help relieve pain and reduce fever. Many pe...ol and prescription brand names, Vicodin and Perco... on June 30, 2009 to address liver related injurie...voted 20-17 to urge the FDA to put a ban on Vicodi...
(Date:7/2/2009)...swire/ -- A new analysis of the incidence of breas...es of 0 to 84 from 2000 to 2005 shows a 72 percent...stry of Health, with the sharpest uptick of +28.6 ...25 to 44). , , The new results, which rely on h...urgeries rather than official estimations computed...
(Date:7/2/2009)...titis B virus (HBV) are associated with the develo...atients with HBV infections are at increased risk ... in the Journal of the National Cancer Institute ...known cause of hepatocellular carcinoma (HCC), the...s have looked at whether patients with specific mu...
(Date:7/2/2009)...chytherapy and remain free of disease for five yea... 10 years, according to a study in the July 1 issu...ogy*Biology*Physics , the official journal of the ... Brachytherapy is the placement of radioactive sou... or temporarily, depending upon the cancer. , In ...
Breaking Medicine News(10 mins):Health News:Viles & Beckman, LLC: Stop Your Headache NOT Your Liver 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3
...Indian-American boy underwent a simultaneous liver..., which the attending doctors claimed as the first...was suffering from a disease known as primary Hype...an enzyme resulting in accumulation of calcium in ...
... that life is a dream as you row merrily down the ...nto the streams around Portland as part of the na...s and its source in the water systems. This exerc...medicines and coffee sediments in the water bed. T...
...ident Bill Clinton has once again lent a helping h...n the Brazil government and drug giant Merck over...ion has helped diffuse the situation. Clinching a...pla and Matrix, Bill Clinton announced the tie-up ...
...od test could predict relapse or survival for chil...chers from the Children's Cancer Hospital at The ...eported. A review of young leukemia patients ove...solute lymphocyte count (ALC), a measure of normal...
Other Medicine News:Health News:NRI Boy Underwent a Rare Dual Transplant Surgery 2Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Lymphocyte Count Found to Be a Predictor of Survival for Young Patients With Leukemia 2
(Date:6/26/2009)..."Agendia,s Breast Cancer Recurrence Test MammaPrin...sensus Recommendations" issued,on 23 Jun 2009 12:...e advised,that the subheadline was missing from t...ire. Complete, corrected release follows: , ...ncer Recurrence Test MammaPrint Included in,Inter...
(Date:6/26/2009)...ds Approval of New Anti-TNF Therapy in Three Rheum...r , , HORSHAM, Pa. and KENILWORTH, N.J., June 2... Inc. and Schering-Plough Corporation (NYSE: SGP...l Products for Human Use (CHMP) of the European Me...ecommending the approval of SIMPONI(TM) (golimumab...
(Date:6/25/2009)...wire-USNewswire/ -- As of mid-2009, The Michael J....dy funded over $1 million in high-risk, high-rewar...t through its groundbreaking Rapid Response Innov...the safety and efficacy of an FDA-approved drug fo...ation of a tenuous link between PD and certain str...
(Date:6/25/2009)...ent Covering ARIKACE for Once-Daily Treatment of P...N, N.J., June 25 Cystic Fibrosis F...te of the Cystic Fibrosis Foundation, has provided...ntinued development of ARIKACE(TM) (liposomal amik...reat Pseudomonas lung infections in cystic fibro...
Breaking Medicine Technology:/C O R R E C T I O N -- Agendia B.V./ 2/C O R R E C T I O N -- Agendia B.V./ 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 2MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 1Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 2Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall 40046 3Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 1Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 2Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 3Frost 26 Sullivan Lauds Pioneer Surgical Technology for Development of Tissue Scaffold E Matrix 40044 4XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 1XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 2XTENT Receives CE Mark Approval for CUSTOM NX 28R 29 Drug Eluting Stent System 40042 3LUMEDX Launches New Interventional Radiology Software 11091 1LUMEDX Launches New Interventional Radiology Software 11091 2
...wire/ -- Researchers from the,Barbara Ann Karmanos...evidence today that an antibiotic typically prescr...n eventually treating,certain types of cancers. , ...Karmanos, and,members of his lab announced the fin...nol (CQ) appears to have an anti-tumor effect,in m...
...urea derivative compound series show highly,sele...cancer,treatment , , QUBEC CITY, Canada, Ap...daq:,AEZS), a global, pure play biopharmaceutica...ogy, today presented an abstract,outlining first...,with high selectivity for PI3K inhibition, at the...
Other Medicine Technology:Alzheimer's Drug Shows Promise in Fighting Cancer 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3terna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 4
Hospital Base or Surgical Center where heavy use is a requirement. Keeler, the first name in Cryo Ophthalmic Surgery has been supplying the Ophthalmic Surgeon with high performance, reliable Cryo Sy
...ilable option to correct atrial septal defects in ...ealth factors. Today's health care providers are s...defects., ,The GORE HELEX Septal Occluder is a...ivery system indicated for the transcatheter closu...
...ing and management consulting firm specializing in...y improvement, quality control, and cost reduction...g, lean enterprise, and six sigma techniques to de...t drive and sustain operational excellence. Labora...
...ing and management consulting firm specializing in...y improvement, quality control, and cost reduction...g, lean enterprise, and six sigma techniques to de...t drive and sustain operational excellence. Labora...
Medicine Products: